David Joseph Topper Arcutis Biotherapeutics, Inc. (ARQT) insider trading activity

David Joseph Topper is Chief Financial Officer of Arcutis Biotherapeutics, Inc.. Currently has a direct ownership of 158,374 shares of ARQT, which is worth approximately $2.37 Million. The most recent transaction as insider was on Sep 24, 2024, when has been sold 11,626 shares (Common Stock) at a price of $9.48 per share, resulting in proceeds of $110,214. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 158K

0% 3M change

n/a 12M change

Total Value Held $2.37 Million

David Joseph Topper Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 24 2024	SELL Open market or private sale	$110,214 $9.48 p/Share	11,626 Reduced 6.84%	158,374 Common Stock
Sep 21 2024	BUY Grant, award, or other acquisition	-	60,000 Added 26.09%	170,000 Common Stock
Apr 10 2024	BUY Grant, award, or other acquisition	-	110,000 Added 50.0%	110,000 Common Stock

Also insider at

FLAC

Frazier Lifesciences Acquisition Corp Financial Services

Chief Financial Officer

DJT